Yukun Li

Prof. Yukun Li


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2012 in Endocrine
Verified
Journal Article
Closed access
PDF file
PXPeng Xue
Peng Xue
PGPing Gao
Ping Gao
YLYukun Li
Yukun Li


1 January 2013 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
PXPeng Xue
Peng Xue
YWYan Wang
Yan Wang
JYJie Yang
Jie Yang
YLYukun Li
Yukun Li
Objectives. Growth hormone deficiency patients exhibited reduced bone mineral density compared with healthy controls, but previous researches demonstrated uncertainty about the effect of growth hormone replacement therapy on bone in growth hormone deficient adults. The aim of this study was to determine whether the growth hormone replacement therapy could elevate bone mineral density in growth hormone deficient adults.Methods. In this meta-analysis, searches of Medline, Embase, and The Cochrane Library were undertaken to identify studies in humans of the association between growth hormone treatment and bone mineral density in growth hormone deficient adults. Random effects model was used for this meta-analysis.Results. A total of 20 studies (including one outlier study) with 936 subjects were included in our research. We detected significant overall association of growth hormone treatment with increased bone mineral density of spine, femoral neck, and total body, but some results of subgroup analyses were not consistent with the overall analyses.Conclusions. Our meta-analysis suggested that growth hormone replacement therapy could have beneficial influence on bone mineral density in growth hormone deficient adults, but, in some subject populations, the influence was not evident.

26 November 2014 in Health and Quality of Life Outcomes
Verified
Journal Article
Open access
PDF file
WYWenying Yang
Wenying Yang
XZXiaoming Zhuang
Xiaoming Zhuang
YLYukun Li
Yukun Li
QWQing Wang
Qing Wang
RBRongwen Bian
Rongwen Bian
LYLi Yang
Li Yang
Based on the 24-week, prospective, non-interventional, observational study, A1chieve®, we investigated how health-related quality of life (HRQoL) changed, and the predictors of such changes, in Chinese people with type 2 diabetes mellitus (T2DM) after starting with, or switching to, biphasic insulin aspart 30 (BIAsp 30). In total, 8,578 people with T2DM starting treatment with, or switching to, BIAsp 30 were recruited from 130 urban hospitals in China. HRQoL was assessed at baseline and 24 weeks using the EuroQol-5 dimensions (EQ-5D) questionnaire. Descriptive statistics, paired t-test, and chi-square test were conducted and the linear ordinary least squares regression model was used to determine predictors for changes in EQ-5D score. Haemoglobin A1c (HbA1c) decreased from 9.5% to 7.0% after 24 weeks. The reported HRQoL measured by the EQ-5D visual analogue scale score increased by 6.2 (p < 0.001) from 75.8 to 82.0, and EQ-5D index score increased by 0.018 (p < 0.001) from 0.875 to 0.893 for the cohort over 24 weeks. The percentage of patients reporting no problems in the mobility, pain/discomfort, and anxiety/depression dimensions of EQ-5D increased significantly (p < 0.001) from 88.4% to 91.4%, 77.3% to 82.8%, and 74.2% to 77.1%, respectively. Patients with higher HbA1c levels at baseline, major hypoglycaemia or micro-complications exhibited significantly larger changes in EQ-5D scores than those with lower baseline HbA1c levels, without major hypoglycaemia or micro-complications after controlling for demographics and other baseline characteristics. BIAsp 30 treatment was associated with improved glycaemic control and HRQoL in T2DM patients in China. Patients with worse health conditions were more likely to experience larger improvements in HRQoL than those with better health conditions. ClinicalTrials.gov, NCT00869908 .

2 February 2013 in Endocrine
Verified
Journal Article
Closed access
PDF file
YWYan Wang
Yan Wang
BLBaoxin Li
Baoxin Li
WZWei Zhang
Wei Zhang
YLYan Liu
Yan Liu
PXPeng Xue
Peng Xue
YLYukun Li
Yukun Li

29 March 2017 in Journal of Clinical Lipidology
Verified
Journal Article
Closed access
PDF file
MTMeimei Tian
Meimei Tian
YLYan Liu
Yan Liu
ZZZhongji Zhi
Zhongji Zhi
YLYukun Li
Yukun Li